El-Hassar L., Amara A., Sanson B., Lacatus O., Belhouchet, AA, Kroneman M., Claeys K., Plancon, JP, Rodolico C., Primiano G., Trojsi F., Filosto M., Mongini T.E., Bortolani S., Monforte M., Carraro E., Maggi L., Ricci F., Silani V., Orsucci D., Créange A., Péréon Y., Stojkovic T., van der Beek, NAME, Toscano A., Pareyson D., Attarian S., Van den Bergh, PYK, Remiche G., Hoeijmakers, JGJ, Badrising U., Voermans N.C., Kaindl A.M., Schara-Schmidt U., Schoser B., Gazzerro E., Haberlová J., Vohanka, S, Pál E., Molnar M.J., Leonardis L., Tournev I.L., Osorio A.N., Olivé M., Muelas N., Alonso-Perez J., Plá F., De Visser M., Siciliano G., Sacconi S.. Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey. Journal Of Neuromuscular Diseases. 2023; 10(2)DOI:10.3233/JND-221525. PMID:36373291. IF:3.200(Q2/3D).

Blanco Y., Escudero D., Lleixà C., Llufriu S., Egri N., García R.R., Alba M., Aguilar E., Artola M., Aldea Novo M., Alvarez S., Caballero E., Cabrera-Maqueda J.M., Fonseca E., Guasp M., Hernando A., Martinez-Hernandez E., Olivé-Cirera G., Lopez-Contreras J., Martín-Aguilar L., Martinez-Martinez L., Rombauts A., Rodés M., Sabater L., Sepulveda M., Solana E., Tejada-Illa C., Vidal-Fernández N., Vilella A., Fortuny C., Armangué T., Dalmau J.O., Querol L., Saiz A.. mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(6)DOI:10.1212/NXI.0000000000200163. PMID:37679040. IF:(Q/D).

Al-Hakem H., Doets A.Y., Stino A.M., Zivkovic S.A., Andersen H., Willison H.J., Cornblath D.R., Gorson K.C., Islam Z., Mohammad Q.D., Sindrup Sø.H., Kusunoki S., Davidson A., Casasnovas C., Bateman K., Miller J.A.L., Van Den Berg B., Verboon C., Roodbol J., Leonhard S.E., Arends S., Luijten L.W.G., Benedetti L., Kuwabara S., Van Den Bergh P., Monges S., Marfia G.A., Shahrizaila N., Galassi G., Pereon Y., Burmann J., Kuitwaard K., Kleyweg R.P., Marchesoni C., Tous M.J.S., Querol L., Martin-Aguilar L., Wang Y., Nobile-Orazio E., Rinaldi S., Schenone A., Pardo J., Vermeij F.H., Waheed W., Lehmann H.C., Granit V., Stein B., Cavaletti G., Gutierrez-Gutierrez G., Barroso F.A., Visser L.H., Katzberg H.D., Dardiotis E., Attarian S., Van Der Kooi A.J., Eftimov F., Wirtz P.W., Samijn J.P.A., Jacobus Gilhuis H., Hadden R.D.M., Holt J.K.L., Sheikh K.A., Kolb N., Karafiath S., Vytopil M., Antonini G., Feasby T.E., Faber C., Kramers H., Busby M., Roberts R.C., Silvestri N.J., Fazio R., Van Dijk G.W., Garssen M.P.J., Verschuuren J., Harbo T., Jacobs B.C.. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome. NEUROLOGY. 2023; 100(23)DOI:10.1212/WNL.0000000000207282. PMID:37076309. IF:8.400(Q1/1D).

Vesperinas-Castro A., Cortés-Vicente E.. Rituximab treatment in myasthenia gravis. Frontiers in Neurology. 2023; 14DOI:10.3389/fneur.2023.1275533. PMID:37849836. IF:2.700(Q2/4D).

Mieites V., Pardo A., Gutiérrez-Gutiérrez J.A., Suárez-Calvet X., López-Higuera J.M., Díaz-Manera J., Conde O.M.. Colorimetric fusion of attenuation and birefringence in OCT signatures: a screening tool for evaluating muscular degradation in alpha-sarcoglican deficit murine models. Proceedings of SPIE. 2023; 12632DOI:10.1117/12.2670555. PMID:. IF:(Q/D).

Mieites V., Gutíerrez-Gutíerrez J.A., Pardo A., Súarez-Calvet X., Lopez-Higuera J.M., Diaz-Manera J., Conde O.M.. Wide-field optical properties estimation of whole limbs in muscle dystrophy murine models via SFDI: A case study. Proceedings of SPIE. 2023; 12627DOI:10.1117/12.2670573. PMID:. IF:(Q/D).

Santos García D, de Deus Fonticoba T, Cores C, Castro ES, Hernández Vara J, Jesús S, Mir P, Cosgaya M, Martí MJ, Pastor P, Cabo I, Seijo M, Legarda I, Vives B, Caballol N, Rúiz Martínez J, Croitoru I, Cubo E, Miranda J, Alonso Losada MG, Labandeira C, López Ariztegui N, Morales-Casado M, González Aramburu I, Infante J, Escalante S, Bernardo N, Blázquez Estrada M, Menéndez González M, Caldentey JG, Borrué C, Vela L, Catalán MJ, Gómez Mayordomo V, Kurtis M, Prieto C, Ordás C, Nogueira V, López Manzanares L, Ávila Rivera MA, Puente V, García Moreno JM, Solano Vila B, Álvarez Sauco M, Carrillo Padilla F, Carlos Martínez Castrillo J, Sánchez Alonso P, Gastón I, Kulisevsky J, Valero C, de Fábregues O, González Ardura J, López Díaz LM, Martinez-Martin P. Falls Predict Acute Hospitalization in Parkinson's Disease.. Journal of Parkinsons Disease. 2023; 13(1)DOI:10.3233/JPD-212539. PMID:33843696. IF:4.000(Q2/3D).

Gironell A., Pascual-Sedano B., Marín-Lahoz J., Pérez J., Pagonabarraga J.. Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients. Movement Disorders Clinical Practice. 2023; 10(1)DOI:10.1002/mdc3.13576. PMID:36704076. IF:2.600(Q2/5D).

Gonzalez-Herrero, B, Morgante, F, Pagonabarraga, J, Stanton, B, Edwards, MJ. Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders. Journal of Clinical Medicine. 2023; 12(1)DOI:10.3390/jcm12010299. PMID:36615098. IF:3.000(Q1/2D).

Gil-Polo, C, Martinez-Horta, SI, Santalo, FS, Martin-Palencia, M, Gundin-Menendez, S, Alvarez-Banos, P, Maza-Pereg, L, Calvo, S, Collazo, C, Alonso-Garcia, E, Rinones-Mena, E, Arrabal-Alonso, A, Rodriguez, JN, Saiz-Rodriguez, M, Aguado, L, Mariscal, N, Munoz-Siscart, I, Pineiro, D, Rivadeneyra, J, Diez-Fairen, M, Miguel-Perez, I, Cubo, E. Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease. Movement Disorders Clinical Practice. 2023; 10(2)DOI:10.1002/mdc3.13613. PMID:36825059. IF:2.600(Q2/5D).

Sampedro F., Puig-Davi A., Martinez-Horta S., Pagonabarraga J., Horta-Barba A., Aracil-Bolaños I., Kulisevsky J.. Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson's disease. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 224DOI:10.1016/j.clineuro.2022.107531. PMID:36455303. IF:1.800(Q2/5D).

Santos-García D., Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesús S., Buongiorno M.T., Planellas L., Cosgaya M., Caldentey, JG, Caballol N., Legarda I., Vara, JH, Cabo I., Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira V., Puente V., Garcia-Soto, JD, Borrué C., Vila, BS, Sauco, MA, Vela L., Escalante S., Cubo E., Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón I., Kulisevsky J., Gonzalez, MM, Seijo M., Martinez, JR, Valero C., Kurtis M., Ardura, JG, Redondo, RA, Ordás C., Diaz, LML, McAfee D., Martinez-Martin P., Mir P.. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness. Journal of Parkinsons Disease. 2023; 13(2)DOI:10.3233/JPD-225014. PMID:36683517. IF:4.000(Q2/3D).

Martínez M., Ariz M., Alvarez I., Castellanos G., Aguilar M., Hernández-Vara J., Caballol N., Garrido A., Bayés À., Vilas D., Marti M.J., Pascual-Sedano B., Marin J., Avila A., Buongiorno M., Tartari J.P., Puente V., Ezquerra M., Valldeoriola F., Compta Y., Tolosa E., Pont C., Pastor P., de Solórzano C.O., Pastor M.A.. Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease. npj Parkinsons Disease. 2023; 9(1)DOI:10.1038/s41531-023-00503-2. PMID:37061532. IF:6.700(Q1/1D).

Butjosa, A, Usall, J, Vila-Badia, R, Mezquida, G, Cuesta, MJ, Rodriguez-Toscano, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Espliego, A, Corripio, I, Vieta, E, Baeza, I, Berge, D, Bernardo, M. Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. 2023; 69(1)DOI:10.1177/00207640211070398. PMID:35068217. IF:2.500(Q2/5D).

Segura, AG, Mezquida, G, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Moreno-Izco, L, Amoretti, S, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan-Bejarano, A, Vieta, E, de la Serna, E, Toll, A, Cuesta, MJ, Mas, S, Bernardo, M. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. PSYCHOLOGICAL MEDICINE. 2023; 53(10)DOI:10.1017/S0033291722001544. PMID:35678455. IF:5.900(Q1/1D).

Porta-Casteràs D., Cano M., Navarra-Ventura G., Serra-Blasco M., Vicent-Gil M., Solé B., Montejo L., Torrent C., Martinez-Aran A., Harrison B.J., Palao D., Vieta E., Cardoner N.. Disrupted network switching in euthymic bipolar disorder: Working memory and self-referential paradigms. JOURNAL OF AFFECTIVE DISORDERS. 2023; 320DOI:10.1016/j.jad.2022.09.152. PMID:36202301. IF:4.900(Q1/2D).

Lin, BD, Pinzon-Espinosa, J, Blouzard, E, van der Horst, MZ, Okhuijsen-Pfeifer, C, van Eijk, KR, Guloksuz, S, Peyrot, WJ, Luykx, JJ. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia. JAMA Psychiatry. 2023; 80(2)DOI:10.1001/jamapsychiatry.2022.4234. PMID:36542388. IF:22.500(Q1/1D).

Blanken M.A.J.T., Oudega M.L., Hoogendoorn A.W., Sonnenberg C.S., Rhebergen D., Klumpers U.M.H., Van Diermen L., Birkenhager T., Schrijvers D., Redlich R., Dannlowski U., Heindel W., Coenjaerts M., Nordanskog P., Oltedal L., Kessler U., Frid L.M., Takamiya A., Kishimoto T., Jorgensen M.B., Jorgensen A., Bolwig T., Emsell L., Sienaert P., Bouckaert F., Abbott C.C., Péran P., Arbus C., Yrondi A., Kiebs M., Philipsen A., van Waarde J.A., Prinsen E., van Verseveld M., Van Wingen G., ten Doesschate F., Camprodon J.A., Kritzer M., Barbour T., Argyelan M., Cardoner N., Urretavizcaya M., Soriano-Mas C., Narr K.L., Espinoza R.T., Prudic J., Rowny S., van Eijndhoven P., Tendolkar I., Dols A.. Sex-specifics of ECT outcome. JOURNAL OF AFFECTIVE DISORDERS. 2023; 326DOI:10.1016/j.jad.2022.12.144. PMID:36632848. IF:4.900(Q1/2D).

Sastre-Buades A., Caro-Cañizares I., Ochoa S., Lorente-Rovira E., Barajas A., Gutiérrez-Zotes A., Sánchez-Alonso S., López-Carrilero R., Grasa E., Pousa E., Pélaez T., Cid J., González-Higueras F., Ruiz-Delgado I., Baca-Garcia E., Barrigon M.L.. Relationship between cognition and suicidal behavior in recent-onset psychosis. SCHIZOPHRENIA RESEARCH. 2023; 252DOI:10.1016/j.schres.2022.12.042. PMID:36652834. IF:3.600(Q1/3D).

Gutiérrez F., Aluja A., Rodríguez C., Gárriz M., Peri J.M., Gallart S., Calvo N., Ferrer M., Gutiérrez-Zotes A., Soler J., Pascual J.C.. Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sample. Frontiers in Psychiatry. 2023; 13DOI:10.3389/fpsyt.2022.1015489. PMID:36699492. IF:3.200(Q2/4D).